StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)

Close on Nov 18, 2026Market cap $8.09MP/E –Yield –

Radiopharm Theranostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2026 it was -$56.78M.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$56.78M–
FY2025Jun 30, 2025-$38.17M–
FY2024Jun 30, 2024-$47.21M–
FY2023Jun 30, 2023-$34.49M–

More Radiopharm Theranostics figures

See a number that looks wrong?